Clearside Biomedical - 53 Year Dividend History | CLSD
Historical dividend payout and yield for Clearside Biomedical (CLSD) since 1971. The current TTM dividend payout for Clearside Biomedical (CLSD) as of April 24, 2024 is $0.00. The current dividend yield for Clearside Biomedical as of April 24, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.102B |
$0.008B |
|
Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space(TM) microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
